The rate of freedom from breast cancer at @ years was @ % in the exemestane-ovarian suppression group , as compared with @ % in the tamoxifen-ovarian suppression group ( hazard ratio for recurrence , @ ; @ % CI , @ to @ ; P < @ ) .